Anne J. Stone

1.3k total citations
10 papers, 220 citations indexed

About

Anne J. Stone is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Anne J. Stone has authored 10 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Anne J. Stone's work include Cystic Fibrosis Research Advances (4 papers), Pediatric health and respiratory diseases (2 papers) and Platelet Disorders and Treatments (2 papers). Anne J. Stone is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Pediatric health and respiratory diseases (2 papers) and Platelet Disorders and Treatments (2 papers). Anne J. Stone collaborates with scholars based in United States, United Kingdom and Canada. Anne J. Stone's co-authors include Robin Mukherjee, James B. Bussel, Steven M. Rowe, Frank J. Accurso, Qunming Dong, Claudia L. Ordoñez, Melissa A. Ashlock, Fredrick Van Goor, Jiuhong Zha and Bonnie W. Ramsey and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and American Journal of Hematology.

In The Last Decade

Anne J. Stone

10 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne J. Stone United States	5	157	33	26	22	21	10	220
Mohamed Nabil Salem Egypt	9	66 0.4×	18 0.5×	36 1.4×	9 0.4×	4 0.2×	20	188
Joshua Hessler United States	5	47 0.3×	15 0.5×	13 0.5×	37 1.7×	25 1.2×	7	143
Sébastien Orazio France	5	29 0.2×	28 0.8×	14 0.5×	24 1.1×	15 0.7×	15	107
Miryoung Kim United States	5	162 1.0×	13 0.4×	6 0.2×	31 1.4×	41 2.0×	7	210
Alison Turner United Kingdom	7	93 0.6×	6 0.2×	23 0.9×	75 3.4×	11 0.5×	24	218
Marwa Abu El Haija United States	7	61 0.4×	15 0.5×	20 0.8×	50 2.3×	9 0.4×	21	196
Benedetta Fabrizzi Italy	8	105 0.7×	5 0.2×	7 0.3×	21 1.0×	12 0.6×	20	151
Daniel S. Glass United States	4	230 1.5×	4 0.1×	50 1.9×	48 2.2×	7 0.3×	6	286
Vidya Raman United States	5	86 0.5×	5 0.2×	36 1.4×	21 1.0×	10 0.5×	7	180
J.L. Patier de la Peña Spain	7	35 0.2×	14 0.4×	16 0.6×	12 0.5×	28 1.3×	29	125

Countries citing papers authored by Anne J. Stone

Since Specialization

Citations

This map shows the geographic impact of Anne J. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne J. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne J. Stone more than expected).

Fields of papers citing papers by Anne J. Stone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne J. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne J. Stone. The network helps show where Anne J. Stone may publish in the future.

Co-authorship network of co-authors of Anne J. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Anne J. Stone. A scholar is included among the top collaborators of Anne J. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne J. Stone. Anne J. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Accurso, Frank J., Fredrick Van Goor, Jiuhong Zha, et al.. (2013). Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data. Journal of Cystic Fibrosis. 13(2). 139–147. 111 indexed citations

Rowe, Steven M., Bo Liu, Heather Hathorne, et al.. (2013). Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation. PLoS ONE. 8(7). e66955–e66955. 40 indexed citations

Ratjen, Félix, Helen Sheridan, Po‐Shun Lee, et al.. (2012). Effect of ivacaftor on lung clearance index and FEV1 in subjects with CF who have the G551D-CFTR mutation and mild lung disease. 40. 1841. 1 indexed citations

Vicencio, Alfin G., et al.. (2012). Severe Asthma With Fungal Sensitization In Children: Characterization Of A New Pediatric Asthma Sub-Phenotype. A4068–A4068. 1 indexed citations

Ratjen, Félix, Helen Sheridan, Po‐Shun Lee, et al.. (2012). Lung Clearance Index As An Endpoint In A Multicenter Randomized Control Trial Of Ivacaftor In Subjects With Cystic Fibrosis Who Have Mild Lung Disease. A2819–A2819. 4 indexed citations

Mita, Alain C., Anthony J. Olszanski, Richard C. Walovitch, et al.. (2007). Phase I and Pharmacokinetic Study of AI-850, A Novel Microparticle Hydrophobic Drug Delivery System for Paclitaxel. Clinical Cancer Research. 13(11). 3293–3301. 13 indexed citations

Costello, Cynthia B., Vanessa R. Wight, & Anne J. Stone. (2002). The American Woman 2003–2004. Palgrave Macmillan US eBooks. 4 indexed citations

Bussel, James B., Robin Mukherjee, & Anne J. Stone. (2001). A pilot study of rhuIL-11 treatment of refractory ITP. American Journal of Hematology. 66(3). 172–177. 36 indexed citations

Bussel, James B., Robin Mukherjee, & Anne J. Stone. (2001). A pilot study of rhuIL‐11 treatment of refractory ITP. American Journal of Hematology. 66(3). 172–177. 1 indexed citations

10.

Dykstra, Kevin, et al.. (2000). Mechanism and Amelioration of Recombinant Human Interleukin‐11 (rhIL‐11)–Induced Anemia in Healthy Subjects. The Journal of Clinical Pharmacology. 40(8). 880–888. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact